Your browser doesn't support javascript.
loading
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira, Teresa; Ferreira, Luciana L; Coelho, Ana Raquel; Deus, Cláudia M; Oliveira, Paulo J.
Afiliación
  • Cunha-Oliveira T; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal. Electronic address: teresa.oliveira@uc-biotech.pt.
  • Ferreira LL; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal.
  • Coelho AR; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
  • Deus CM; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
  • Oliveira PJ; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
Toxicol Appl Pharmacol ; 348: 1-13, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29653124

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Proteína p53 Supresora de Tumor / Miocitos Cardíacos / Metabolismo Energético / Células Madre Pluripotentes Inducidas / Cardiopatías / Antibióticos Antineoplásicos Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Proteína p53 Supresora de Tumor / Miocitos Cardíacos / Metabolismo Energético / Células Madre Pluripotentes Inducidas / Cardiopatías / Antibióticos Antineoplásicos Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2018 Tipo del documento: Article